Navigating Thyroid Cancer Treatments: Papillary vs. Follicular Subtypes Thyroid cancer is a complicated disease that needs individualized treatment methods. There are two main types of differentiated thyroid cancer: papillary thyroid…
What Does it Mean to have “Differentiated Thyroid Cancer”? In my previous blog, I described a number of subtypes of thyroid cancer. What if your doctor told you that you…
Demystifying Thyroid Cancer Subtypes There are several different types of thyroid cancer, each with its own characteristics and treatment approaches. In this article, we will discuss the most common types…
Thyroid Cancer: Understanding Diagnosis, and Treatment Thyroid cancer has emerged as a significant concern in recent years. Its incidence appears to be increasing. The reason for this is not completely…
Listen to our CEO, Dr. Oliver Bathe talk about Qualisure's innovation and the work he's done to transition from being a medical practitioner to a full-time entrepreneur. CLICK HERE TO…
October 19-23 2022. Dr. Oliver Bathe presented results from a study of 742 patients at the 2022 Annual Meeting of the American Thyroid Association. The study demonstrated that Thyroid GuidePx®…
CALGARY, ALBERTA, Recently Jon Hagan, Senior Business Partner in Marketing and Communications at Alberta Innovates, sat down with our CEO Dr. Oliver Bathe. Jon explored the Qualisure commercialization journey with…
Qualisure Diagnostics is pleased to announce the launch of our first diagnostic test, Thyroid GuidePx® for papillary thyroid cancer, the most common type of thyroid cancer. Thyroid GuidePx® is the…
Dr. Cynthia Stretch (Chief Scientific Officer) presented details on the molecular features of molecular subgroups of papillary thyroid cancer that are identifiable using Thyroid GuidePx™ at the Annual Meeting of…
Qualisure has submitted an international PCT patent application for the molecular subclassification of papillary thyroid cancer which is ending review. The Patent Cooperation treaty (PCT) is an international treaty with…
